Security key
67080N101
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 339,200,672
- Total 13F shares
- 224,729,650
- Share change
- +17,374,617
- Total reported value
- $439,155,420
- Put/Call ratio
- 9.6%
- Price per share
- $1.95
- Number of holders
- 179
- Value change
- +$34,613,471
- Number of buys
- 121
- Number of sells
- 50
Report period
Q2 2025
Institutions
179
Top holders
10
NUVB full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Nuvation Bio Inc. SEC filings
Nuvation Bio Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 67080N101
Recent filing periods:
Top shareholders of NUVB - Nuvation Bio Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13D/G
13F
|
Company |
15%
|
50,599,225
|
$110,306,310 | +$11,583,764 | 31 Mar 2025 | |
| BlackRock, Inc. |
13D/G
13F
|
Company |
6.4%
|
21,708,843
|
$42,332,244 | +$10,273,842 | 30 Jun 2025 | |
| Decheng Capital LLC |
13F
|
Company |
7.7%
|
25,954,439
|
$45,679,813 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.5%
|
15,397,820
|
$27,100,164 | — | 31 Mar 2025 | |
| Omega Fund Management, LLC |
13F
|
Company |
3.9%
|
13,072,340
|
$23,007,318 | — | 31 Mar 2025 | |
| Laurion Capital Management LP |
13F
|
Company |
2.9%
|
9,871,077
|
$17,373,096 | — | 31 Mar 2025 | |
| Octagon Capital Advisors LP |
13F
|
Company |
2.3%
|
7,900,000
|
$13,904,000 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
5,130,604
|
$9,032,245 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.4%
|
4,856,016
|
$8,546,588 | — | 31 Mar 2025 | |
| MPM BioImpact LLC |
13F
|
Company |
1.4%
|
4,652,243
|
$8,187,948 | — | 31 Mar 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.1%
|
3,900,000
|
$6,864,000 | — | 31 Mar 2025 | |
| ABRAMS CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
1.1%
|
3,811,513
|
$6,708,263 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.1%
|
3,774,003
|
$6,642,245 | — | 31 Mar 2025 | |
| Redmile Group, LLC |
13F
|
Company |
0.89%
|
3,031,009
|
$5,334,576 | — | 31 Mar 2025 | |
| Aisling Capital Management LP |
13F
|
Company |
0.75%
|
2,541,009
|
$4,472,176 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.73%
|
2,492,882
|
$4,388,648 | — | 31 Mar 2025 | |
| Rosalind Advisors, Inc. |
13F
|
Company |
0.72%
|
2,451,500
|
$4,314,640 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.62%
|
2,105,846
|
$3,706,288 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.59%
|
2,016,665
|
$3,549,331 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.58%
|
1,969,970
|
$3,467,147 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.56%
|
1,904,141
|
$3,351,288 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.4%
|
1,349,763
|
$2,375,583 | — | 31 Mar 2025 | |
| Knoll Capital Management, LLC |
13F
|
Company |
0.3%
|
1,025,000
|
$1,804,000 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.3%
|
1,024,623
|
$1,803,337 | — | 31 Mar 2025 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.3%
|
1,005,226
|
$1,769,000 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.26%
|
871,692
|
$1,534,178 | — | 31 Mar 2025 | |
| WEXFORD CAPITAL LP |
13F
|
Company |
0.23%
|
772,919
|
$1,360,340 | — | 31 Mar 2025 | |
| Palo Alto Investors LP |
13F
|
Company |
0.23%
|
772,652
|
$1,359,868 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.22%
|
746,094
|
$1,313,125 | — | 31 Mar 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.2%
|
692,673
|
$1,219,104 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.2%
|
687,378
|
$1,209,785 | — | 31 Mar 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.19%
|
661,052
|
$1,163,000 | — | 31 Mar 2025 | |
| AWM Investment Company, Inc. |
13F
|
Company |
0.19%
|
650,000
|
$1,144,000 | — | 31 Mar 2025 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.18%
|
619,258
|
$1,089,894 | — | 31 Mar 2025 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.17%
|
592,119
|
$1,042,129 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.15%
|
518,867
|
$913,206 | — | 31 Mar 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.14%
|
486,535
|
$856,302 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.13%
|
453,792
|
$798,674 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.13%
|
444,100
|
$781,616 | — | 31 Mar 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.13%
|
435,917
|
$767,214 | — | 31 Mar 2025 | |
| Swiss National Bank |
13F
|
Company |
0.13%
|
426,700
|
$750,992 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.11%
|
367,772
|
$647,279 | — | 31 Mar 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.11%
|
358,800
|
$631,488 | — | 31 Mar 2025 | |
| Intellectus Partners, LLC |
13F
|
Company |
0.09%
|
320,905
|
$564,793 | — | 31 Mar 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.08%
|
268,520
|
$472,595 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.07%
|
249,925
|
$439,855 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.07%
|
249,081
|
$438,383 | — | 31 Mar 2025 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.07%
|
245,126
|
$431,422 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.07%
|
231,821
|
$409,000 | — | 31 Mar 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.07%
|
223,632
|
$393,593 | — | 31 Mar 2025 |
Institutional Holders of Nuvation Bio Inc. - Common Stock (NUVB) as of Q2 2025
As of 30 Jun 2025,
Nuvation Bio Inc. - Common Stock (NUVB) was held by
179 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
224,729,650 shares.
The largest 10 holders included
FMR LLC, Decheng Capital LLC, BlackRock, Inc., VANGUARD GROUP INC, Omega Fund Management, LLC, Laurion Capital Management LP, Octagon Capital Advisors LP, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, and CITADEL ADVISORS LLC.
This page lists
180
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
159
Q2 2025 holders
179
Holder diff
20
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.